Evidence map›Paper›PMID 34093025›Full record

ArticleOncoTargets and therapy2021

Acetone Extract of

Ruiqi Xu, Mengnan Zeng, Yuanyuan Wu, Shengchao Wang, Beibei Zhang, Jingke Zhang, Yuxuan Kan, Benke Li, Bing Cao, Xiaoke Zheng and 1 more

Open access · goldAbstract read
In one paragraph

Article in OncoTargets and therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. A comprehensive review ofFrontiers in nutrition · 2023
    Pooled it
  2. Article
  3. Review
  4. Review
  5. Cornelian Cherry (International journal of molecular sciences · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Ruiqi XuSchool of Pharmacy, Henan University of Traditional Chinese Medicine, Zhengzhou, People's Republic of China.
Mengnan ZengSchool of Pharmacy, Henan University of Traditional Chinese Medicine, Zhengzhou, People's Republic of China.
Yuanyuan WuSchool of Pharmacy, Henan University of Traditional Chinese Medicine, Zhengzhou, People's Republic of China.
Shengchao WangSchool of Pharmacy, Henan University of Traditional Chinese Medicine, Zhengzhou, People's Republic of China.ORCID 0000-0002-3504-747X
Beibei ZhangSchool of Pharmacy, Henan University of Traditional Chinese Medicine, Zhengzhou, People's Republic of China.
Jingke ZhangSchool of Pharmacy, Henan University of Traditional Chinese Medicine, Zhengzhou, People's Republic of China.
Yuxuan KanSchool of Pharmacy, Henan University of Traditional Chinese Medicine, Zhengzhou, People's Republic of China.
Benke LiSchool of Pharmacy, Henan University of Traditional Chinese Medicine, Zhengzhou, People's Republic of China.
Bing CaoSchool of Pharmacy, Henan University of Traditional Chinese Medicine, Zhengzhou, People's Republic of China.
Xiaoke ZhengSchool of Pharmacy, Henan University of Traditional Chinese Medicine, Zhengzhou, People's Republic of China.ORCID 0000-0003-3671-231X
Weisheng FengSchool of Pharmacy, Henan University of Traditional Chinese Medicine, Zhengzhou, People's Republic of China.
Henan University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis research aims to investigate the intervention and mechanism of 50% acetone extract of PATIENTS AND

methodsTumor size and cardiac function were measured via ultrasound. The accumulation of 2-deoxy-D-glucose (2-DG) in tumor tissue was examined with near-infrared in vivo imaging. Flow cytometry was performed to assess apoptosis and reactive oxygen species (ROS) levels in tumor and immune cells in spleen. The levels of inflammatory cytokines in serum were detected by cytometric bead array. The expression of proliferation-, apoptosis-, and angiogenesis-related proteins in tumor cells was measured to evaluate the underlying mechanisms. Subsequently, the effects of four compounds separated from SZYY on the proliferation and migration of A375 cells and STAT3 signaling were examined. The peak identification and contents of the four components were performed via high-performance liquid chromatography (HPLC). Finally, we evaluated the inhibitory effects of STAT3 overexpression on the cytotoxic activity of four constituents in A375 cells.

resultsSZYY inhibited the growth and glycolysis of melanoma xenograft in mice, improved cardiac function, increased the percentages of macrophages, neutrophils, and lymphocytes in spleen, reduced the levels of IL-6, IL-17A, TNF-α, and IFN-γ in serum, promoted apoptosis and oxidative stress in tumor tissues, and inhibited STAT3 phosphorylation and expression of angiogenic factors. Chemical analysis showed that SZYY is rich in loganin, rutin, triohimas C, and triohimas D, which all could restrain the proliferation and migration of A375 cells and inhibit the phosphorylation and nuclear translocation of STAT3. Moreover, STAT3 overexpression could diminish the cytotoxic activity of four compounds on A375 cells.

conclusionSZYY could exert anti-melanoma effects via inhibiting STAT3 signaling to induce apoptosis and inhibit tumor angiogenesis. Its active ingredients might be loganin, rutin, triohimas C, and triohimas D.

Indexed as

angiogenesisapoptosisCornus officinalismelanomaSTAT3

Identifiers

PMID34093025
PMCPMC8169088
OpenAlexW3164550335

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.